PILL

Leveraged & Inverse Channel

Big Biopharma Mergers Could Fuel These ETFs in 2019

By Ben HernandezJanuary 10, 2019

Leveraged & Inverse Channel

Pharma Earnings: The PILL to CURE Market Troubles?

By DirexionNovember 1, 2018

Equity ETFs

A Potent Pharmaceuticals ETF

By Brenton GarenJuly 30, 2018

Equity ETFs

Pharma, Biotech Bull ETFs Leading the Charge

By Ben HernandezJuly 12, 2018

Alternative ETFs

Direxion Resuscitates Leveraged Pharmaceutical ETF

By Max ChenNovember 15, 2017

Equity ETFs

Drug Makers, Pharma ETFs Face a Tough Earnings Season

By Max ChenApril 24, 2017

Featured

Direxion Debuts Double Leveraged Cyber Security, Pharmaceuticals ETFs

By Tom LydonSeptember 16, 2015